
Thomas T. Pham
Examiner (ID: 229, Phone: (571)270-7670 , Office: P/1713 )
| Most Active Art Unit | 1713 |
| Art Unit(s) | 1713 |
| Total Applications | 678 |
| Issued Applications | 304 |
| Pending Applications | 113 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14960863
[patent_doc_number] => 20190307909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => PRODUCTION OF 43SC RADIONUCLIDE AND ITS USE IN POSITRON EMISSION TOMOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 16/417956
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16417956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/417956 | PRODUCTION OF 43SC RADIONUCLIDE AND ITS USE IN POSITRON EMISSION TOMOGRAPHY | May 20, 2019 | Abandoned |
Array
(
[id] => 16776638
[patent_doc_number] => 20210113715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => TARGETED NANOPARTICLES FOR DIAGNOSING, DETECTING AND TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/047638
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047638 | TARGETED NANOPARTICLES FOR DIAGNOSING, DETECTING AND TREATING CANCER | Apr 17, 2019 | Abandoned |
Array
(
[id] => 16761119
[patent_doc_number] => 20210106700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 17/044752
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044752 | Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer | Apr 9, 2019 | Pending |
Array
(
[id] => 16955984
[patent_doc_number] => 11059825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => CXCR7 antagonists
[patent_app_type] => utility
[patent_app_number] => 16/379599
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53084
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379599 | CXCR7 antagonists | Apr 8, 2019 | Issued |
Array
(
[id] => 14925219
[patent_doc_number] => 20190298247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => MRI-Based Systems and Methods for Determining Function Capacity of the Kidney
[patent_app_type] => utility
[patent_app_number] => 16/378117
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16378117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/378117 | MRI-based systems and methods for determining function capacity of the kidney | Apr 7, 2019 | Issued |
Array
(
[id] => 16990327
[patent_doc_number] => 20210228747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT AND IMAGING OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/967527
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967527
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967527 | Compositions and methods for the treatment and imaging of cancer | Apr 3, 2019 | Issued |
Array
(
[id] => 16533419
[patent_doc_number] => 10876003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Class of stable heptamethine cyanine fluorophores and biomedical applications thereof
[patent_app_type] => utility
[patent_app_number] => 16/374642
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 27
[patent_no_of_words] => 16314
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16374642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/374642 | Class of stable heptamethine cyanine fluorophores and biomedical applications thereof | Apr 2, 2019 | Issued |
Array
(
[id] => 14578691
[patent_doc_number] => 20190216954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => Ascorbate Formulations and Methods of Use as Contrast Agents
[patent_app_type] => utility
[patent_app_number] => 16/365939
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365939 | Ascorbate formulations and methods of use as contrast agents | Mar 26, 2019 | Issued |
Array
(
[id] => 16939942
[patent_doc_number] => 11052157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
[patent_app_type] => utility
[patent_app_number] => 16/362562
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23675
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/362562 | Enhanced loading of intact, bacterially derived vesicles with small molecule compounds | Mar 21, 2019 | Issued |
Array
(
[id] => 14896881
[patent_doc_number] => 20190292206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => GADOLINIUM COMPLEX, METHOD FOR SYNTHESIS OF THE GADOLINIUM COMPLEX, AND MRI CONTRAST AGENT INCLUDING THE GADOLINIUM COMPLEX
[patent_app_type] => utility
[patent_app_number] => 16/362003
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/362003 | Gadolinium complex, method for synthesis of the gadolinium complex, and MRI contrast agent including the gadolinium complex | Mar 21, 2019 | Issued |
Array
(
[id] => 15239745
[patent_doc_number] => 20190374658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES
[patent_app_type] => utility
[patent_app_number] => 16/356326
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356326 | Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles | Mar 17, 2019 | Issued |
Array
(
[id] => 14564219
[patent_doc_number] => 20190209716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => PET IMAGING OF ZINC TRANSPORT
[patent_app_type] => utility
[patent_app_number] => 16/355335
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16355335
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/355335 | PET imaging of zinc transport | Mar 14, 2019 | Issued |
Array
(
[id] => 16853096
[patent_doc_number] => 20210153841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => THERMO-RESPONSIVE ULTRASOUND COUPLING GEL, AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/978065
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978065 | Thermo-responsive ultrasound coupling gel, and methods and uses thereof | Mar 5, 2019 | Issued |
Array
(
[id] => 14498079
[patent_doc_number] => 20190192694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE
[patent_app_type] => utility
[patent_app_number] => 16/289487
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289487 | COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE | Feb 27, 2019 | Abandoned |
Array
(
[id] => 14464749
[patent_doc_number] => 20190184014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Long-Lived Gadolinium Based Tumor Targeting Imaging and Therapy Agents
[patent_app_type] => utility
[patent_app_number] => 16/285358
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285358 | Long-lived gadolinium based tumor targeting imaging and therapy agents | Feb 25, 2019 | Issued |
Array
(
[id] => 16569226
[patent_doc_number] => 20210008232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/969673
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969673
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969673 | Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer | Feb 21, 2019 | Issued |
Array
(
[id] => 14435787
[patent_doc_number] => 20190175765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/279479
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279479
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279479 | Methods for treating and diagnosing blinding eye diseases | Feb 18, 2019 | Issued |
Array
(
[id] => 18762961
[patent_doc_number] => 11813340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy
[patent_app_type] => utility
[patent_app_number] => 16/967488
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 20089
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967488 | PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy | Feb 5, 2019 | Issued |
Array
(
[id] => 14306547
[patent_doc_number] => 20190142977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => GADOLINIUM-BASED CONTRAST AGENTS FOR SENSITIVE DETECTION OF Zn2+ WITH MRI
[patent_app_type] => utility
[patent_app_number] => 16/246890
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246890
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246890 | Gadolinium-based contrast agents for sensitive detection of Zn | Jan 13, 2019 | Issued |
Array
(
[id] => 14537419
[patent_doc_number] => 20190204331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => REAL-TIME IMAGING SENSOR FOR MEASURING CELLULAR THIOL LEVEL
[patent_app_type] => utility
[patent_app_number] => 16/238371
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16238371
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/238371 | Real-time imaging sensor for measuring cellular thiol level | Jan 1, 2019 | Issued |